The Searle Company Limited

SEARL

PK0061701014

Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
57.04 ^PKR	-0.40%		-1.02%	+10.80%

2023	Euro zone sovereign bond yields approach 8-month low ahead of US data	RE
2023	The Searle Company Limited Announces Board Changes	CI

Searle : Corporate Briefing Session 2023

November 17, 2023 at 06:37 am EST

CORPORATE BRIEFING SESSION

You are cordially invited to the corporate brieﬁng session of The Searle Company Limited

Venue:

Zoom Meeting

Date:

Friday, 24th Nov, 2023

Time:

04:30 - 05:30 PM

For Joining:	Scan QR for Link
Meeting ID: 972 1176 9182
Passcode: 3whSk5

Meeting link:

https://zoom.us/j/97211769182?pwd=

YmRlS3JXV0pCQzk5YTFTRGJmZ08

4Zz09

For any query, please contact

Mr. Sajid Hussain

(Sr. Manager Corporate Compliance) The Searle Company Limited info@searlecompany.com

021 - 37170200-1

Attachments

Original Link
Original Document
Permalink

Disclaimer

Searle Company Ltd. published this content on 17 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2023 11:36:00 UTC.

Latest news about The Searle Company Limited

Euro zone sovereign bond yields approach 8-month low ahead of US data	Dec. 12	RE
The Searle Company Limited Announces Board Changes	Nov. 01	CI
The Searle Company Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-27	CI
Euro zone yields edge lower after Fed remarks, ahead of ECB	23-07-27	RE
Norman Broadbent returns to pre-pandemic levels with revenue boost	23-05-31	AN
The Searle Company Limited agreed to acquire Searle IV Solutions Pvt Ltd and Stellar Ventures Private Limited for INR 7.3 billion.	23-05-24	CI
Indonesia Emerges as Second Largest Cobalt Producer -- Commodities Roundup	23-05-10	DJ
The Searle Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-04-27	CI
The Searle Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-03-02	CI
UK Gilt Remit Expected to Decline to GBP246 Billion in FY2023-24	23-02-22	DJ
The Searle Company Limited has filed an IPO in the amount of PKR 4.544734 billion.	22-12-15	CI
British crime agency recovers $65 million of suspect money in Barclays accounts	22-11-25	RE
UK bond dealers see jump in gilt issuance for 2023/24- Reuters poll	22-11-16	RE
Conservative activist steers U.S. Supreme Court college race cases	22-10-27	RE
The Searle Company Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-10-26	CI
Outlook for Gilts Remains Bearish, Says Citi	22-10-07	DJ
The Searle Company Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-10-03	CI
Analysis-UK bonds and pound at centre of storm as tax shock hammers confidence	22-09-23	RE
The Searle Company Limited(KASE:SEARL) dropped from S&P Global BMI Index	22-09-19	CI
Tesla Legal Chief David Searle Who Led Purchasing Probe Has Left Automaker - Bloomberg News	22-08-17	RE
TESLA LEGAL CHIEF DAVID SEARLE WHO LED PURCHASING PROBE HAS LEFT…	22-08-17	RE
Unilever ups sales guidance after price hikes help it beat forecast	22-07-26	RE
Tesla Executive Facing Scrutiny in Internal Investigation, Bloomberg Says	22-07-21	DJ
The Searle Company Limited acquired OBS Pakistan Limited.	22-05-21	CI
The Searle Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-06	CI

Chart The Searle Company Limited

Duration

Period

More charts

Company Profile

The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Companyâs product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.04 PKR

Average target price

65 PKR

Spread / Average Target

+13.96%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE SEARLE COMPANY LIMITED	+10.80%	79.9M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

The Searle Company Limited

Equities

SEARL

PK0061701014

Pharmaceuticals

Searle : Corporate Briefing Session 2023

Latest news about The Searle Company Limited

Chart The Searle Company Limited

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals